DOI: https://doi.org/10.15587/2519-4852.2017.93393

Pharmaceutical development of the anti-epileptic tablets on the basis of levetiracetam substance. the specificity of pharmaco-technological studies at standardization of the remedy

Eugene Shakin, Natalia Asmolova, Tatyana Yarnykh

Abstract


Remedies containing Levetiracetam are widely used in medical practice for treatment of different forms of epilepsy. In result of pharmaceutical development, manufacturing formulation for the tablets on the basis of Levetiracetam substance was obtained, and the new technology for its production was developed.

The aim of research within the pharmaceutical development of the remedy was to determine the necessity of the complex of operations related to the standardization of the remedies Levetiracetam 250, film coated tablets 250 mg and Levetiracetam 500, film coated tablets 500 mg. Experimental studies should be devoted to determination of quality target product profile (QTPP), according to ICH Q8 recommendations. Concerning the specificity of the mentioned drugs production, the amount of work was determined to develop pharmaco-technological indexes for their implementation to the relevant specifications for the finished drug product, as well as for the intermediate products obtained at different stages of the technological process.

Methods. By results of tests, which were carried out in accordance to pharmacopoeia requirements, the eligibility criteria of pharmaco-technological parameters for the corresponding control objects were determined.

Results. Results of quality target product profile (QTPP) studies were used for development of specifications for the remedies Levetiracetam 250, film coated tablets 250 mg and Levetiracetam 500, film coated tablets 500 mg, which were completed in the form of quality control methods and specifications for the finished drug product series.

Experimental research of the samples of products, which were obtained at appropriate stages of the technological process, were carried out; pharmaco-technological indexes, which were implemented into the specifications for the finished drug product, as well as the specifications for the intermediate products, were developed. According to the given data estimation, it was displayed, that pharmaco-technological indexes are rather important both for the quality of drug assesment, and for evidence base formation to confirm the reproducibility of the technological process.

Conclusion. The results of research within standardization of the remedies Levetiracetam 250, film coated tablets 250 mg and Levetiracetam 500, film coated tablets 500 mg show processability of obtaining drugs, which LLC "Pharma Start" carries out, as well as guarantee of the drugs quality from batch to batch


Keywords


quality target product profile; standardization; specification; eligibility criteria; pharmaco-technological indexes; anti-epileptic tablets; development; technology

References


Vlasov, P. N. (2002). Klinicheskaja harakteristika i perspektivy ispol'zovanija novyh protivojepilepticheskih preparatov u vzroslyh. Farmateka, 1, 25–33.

Gromov, S. A., Mihajlov, V. A., Begi, E. (1997). Jepidemiologija jepilepsii i risk uhudshenija kachestva bol'nyh. Nevrologicheskij zhurnal, 3 (2), 27–30.

Pellock, J. M., Bourgeois, B. F. D., Dodson, E. W., Nordli, D. R., Sankar, R. (Eds.) (2008). Pediatric Epilepsy. Diagnosis and treatment. New York: Demos, 895.

Holtkamp, M., Meierkord, H. (2007). Anticonvulsant, antiepileptogenic, and antiictogenic pharmacostrategies. Cellular and Molecular Life Sciences, 64 (15), 2023–2041. doi: 10.1007/s00018-007-7021-2

Geht, A. B. (2002). Sovremennaja strategija lechenija jepilepsii. Farmateka, 1, 15–24.

Jur'jev, K. L. (2012). Novitni – tret'ogo pokolinnja – protyepileptychni preparaty. Ukrai'ns'kyj medychnyj chasopys, 4, 107–109.

Ljapunov, M., Bezugla, O., Pidpruzhnykov, Ju., Zhemerova, K., Solovjov, O., Tahtaulova, N. (Eds.) (2011). Nastanova 42-3.0:2011. Likars'ki zasoby. Farmacevtychna rozrobka (ICH Q8). Kyiv: MOZ Ukrai'ny, 42.

Georgijevs'kyj, V. (Ed.) (2004). Nastanova 42-3.2:2004. Nastanovy z jakosti. Likars'ki zasoby. Specyfikacii': kontrol'ni vyprobuvannja ta kryterii' pryjnjatnosti. Kyiv: MOZ Ukrai'ny, 38.

Derzhavna Farmakopeja Ukrai'ny. Vol. 1 (2015). Kharkiv: Derzhavne pidpryjemstvo «Ukrai'ns'kyj naukovyj farmakopejnyj centr jakosti likars'kyh zasobiv», 1130.

European Pharmacopoeia current hot topics (2016). European Directorate for the Quality of Medicines and Health Care (EDQM). Strasbourg: Council of Europe, 21.


GOST Style Citations


Власов, П. Н. Клиническая характеристика и перспективы использования новых противоэпилептических препаратов у взрослых [Текст] / П. Н. Власов // Фарматека. – 2002. – № 1. – С. 25–33.

Громов, С. А. Эпидемиология эпилепсии и риск ухудшения качества больных [Текст] / С. А. Громов, В. А. Михайлов, Е. Беги // Неврологический журнал. – 1997. – Т. 3, № 2. – С. 27–30.

Pediatric Epilepsy. Diagnosis and treatment [Text] / J. M. Pellock, B. F. D. Bourgeois, E. W. Dodson, D. R. Nordli, R. Sankar (Eds.). – New York: Demos, 2008. – 895 p.

Holtkamp, M. Anticonvulsant, antiepileptogenic, and antiictogenic pharmacostrategies [Text] / M. Holtkamp, H. Meierkord // Cellular and Molecular Life Sciences. – 2007. – Vol. 64, Issue 15. – P. 2023–2041. doi: 10.1007/s00018-007-7021-2

Гехт, А. Б. Современная стратегия лечения эпилепсии [Текст] / А. Б. Гехт // Фарматека. – 2002. – № 1. – С. 15–24.

Юрьєв, К. Л. Новітні – третього покоління – протиепілептичні препарати [Текст] / К. Л. Юрьєв // Український медичний часопис. – 2012. – № 4. – C. 107–109.

Настанова 42-3.0:2011. Лікарські засоби. Фармацевтична розробка (ICH Q8) [Текст] / ред. М. Ляпунов, О. Безугла, Ю. Підпружников, К. Жемерова, О. Соловйов, Н. Тахтаулова. – К.: МОЗ України, 2011. – 42 с.

Настанова 42-3.2:2004. Настанови з якості. Лікарські засоби. Специфікації: контрольні випробування та критерії прийнятності [Текст] / ред. В. Георгієвський. – К.: МОЗ України, 2004. – 38 с.

Державна Фармакопея України. Т. 1 [Текст]. – Х.: Державне підприємство «Український науковий фармакопейний центр якості лікарських засобів», 2015. – 1130 с.

European Pharmacopoeia current hot topics [Text]. – European Directorate for the Quality of Medicines and Health Care (EDQM). – Strasbourg: Council of Europe, 2016. – 21 p.







Copyright (c) 2017

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2519-4852 (Online), ISSN 2519-4844 (Print)